Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia

• Michael R. McKeown,
• Liv Johannessen,
• Emily Lee,
• Christopher Fiore,
• Emmanuelle di Tomaso

Affiliations

Michael R. McKeown

Syros Pharmaceuticals, Inc, Cambridge, MA, USA

Liv Johannessen

Syros Pharmaceuticals, Inc, Cambridge, MA, USA

Emily Lee

Syros Pharmaceuticals, Inc, Cambridge, MA, USA

Christopher Fiore

Syros Pharmaceuticals, Inc, Cambridge, MA, USA

Emmanuelle di Tomaso

Syros Pharmaceuticals, Inc, Cambridge, MA, USA